Clearside Biomedical Inc (CLSD)
1.03
+0.02
(+1.98%)
USD |
NASDAQ |
Nov 04, 16:00
1.06
+0.03
(+2.91%)
After-Hours: 20:00
Clearside Biomedical Max Drawdown (5Y): 94.66% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 94.66% |
| September 30, 2024 | 94.66% |
| August 31, 2024 | 95.91% |
| July 31, 2024 | 97.07% |
| June 30, 2024 | 97.63% |
| May 31, 2024 | 97.63% |
| April 30, 2024 | 97.63% |
| March 31, 2024 | 97.63% |
| February 29, 2024 | 97.63% |
| January 31, 2024 | 97.63% |
| December 31, 2023 | 97.63% |
| November 30, 2023 | 97.63% |
| October 31, 2023 | 97.63% |
| September 30, 2023 | 97.63% |
| August 31, 2023 | 97.63% |
| July 31, 2023 | 97.63% |
| June 30, 2023 | 97.63% |
| May 31, 2023 | 97.63% |
| April 30, 2023 | 97.63% |
| March 31, 2023 | 97.63% |
| February 28, 2023 | 97.63% |
| January 31, 2023 | 97.63% |
| December 31, 2022 | 97.63% |
| November 30, 2022 | 97.63% |
| October 31, 2022 | 97.63% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.63% |
| August 31, 2022 | 97.63% |
| July 31, 2022 | 97.63% |
| June 30, 2022 | 97.63% |
| May 31, 2022 | 97.63% |
| April 30, 2022 | 97.63% |
| March 31, 2022 | 97.63% |
| February 28, 2022 | 97.63% |
| January 31, 2022 | 97.63% |
| December 31, 2021 | 97.63% |
| November 30, 2021 | 97.63% |
| October 31, 2021 | 97.63% |
| September 30, 2021 | 97.63% |
| August 31, 2021 | 97.63% |
| July 31, 2021 | 97.63% |
| June 30, 2021 | 97.63% |
| May 31, 2021 | 97.63% |
| April 30, 2021 | 97.63% |
| March 31, 2021 | 97.63% |
| February 28, 2021 | 97.63% |
| January 31, 2021 | 97.63% |
| December 31, 2020 | 97.63% |
| November 30, 2020 | 97.63% |
| October 31, 2020 | 97.63% |
| September 30, 2020 | 97.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.66%
Minimum
Sep 2024
97.63%
Maximum
Nov 2019
97.49%
Average
97.63%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Viking Therapeutics Inc | 89.26% |
| Arcus Biosciences Inc | 72.29% |
| Crinetics Pharmaceuticals Inc | 68.70% |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -36.57 |
| Beta (5Y) | 2.330 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 91.18% |
| Historical Sharpe Ratio (5Y) | -0.0713 |
| Historical Sortino (5Y) | -0.1832 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.80% |